LIAN News and Press, LianBio

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...

A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...

SHANGHAI, China and PRINCETON, N.J., Feb. 28, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) (“LianBio” or the “Company”), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that it ha...

2024-02-23 04:32:00 ET Summary The biotech, which obtained rights to novel drugs for use in the Chinese market, has announced a plan to wind up its business and delist from the Nasdaq just four years after being founded. The drug maker will sell its remaining pipeline assets, phas...

2024-02-18 02:05:00 ET Summary LianBio plans to stop all its operations by the end of 2024 and will distribute a $4.80 dividend/share ($528M) to its shareholders. Yiviva signed a memorandum of understanding with AstraZeneca China for an R&D collaboration at AstraZeneca’...

2024-02-15 02:28:35 ET More on LianBio LianBio to wind down its operations, delist its ADS; shares up BofA downgrades LianBio to underperform, cites pipeline optionality Seeking Alpha’s Quant Rating on LianBio Read the full article on Seeking Alpha ...

2024-02-13 08:34:19 ET More on LianBio BofA downgrades LianBio to underperform, cites pipeline optionality Seeking Alpha’s Quant Rating on LianBio Read the full article on Seeking Alpha For further details see: LianBio to wind down its operations, ...

SHANGHAI, China and PRINCETON, N.J., Feb. 13, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN) (“LianBio” or the “Company”), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that ...

2024-02-07 11:28:54 ET More on I-Mab Biopharma Seeking Alpha’s Quant Rating on I-Mab Biopharma Historical earnings data for I-Mab Biopharma Financial information for I-Mab Biopharma Read the full article on Seeking Alpha For further details see...

2024-01-03 09:57:25 ET More on LianBio Johnson & Johnson inks licensing deal with LianBio (update) LianBio confirms buyout offer from Concentra Biosciences Seeking Alpha’s Quant Rating on LianBio Historical earnings data for LianBio Financi...